Medtronic Millenia high-pressure PTCA balloon catheter offers cost savings through reuse, company says.
This article was originally published in The Gray Sheet
MEDTRONIC MILLENIA CATHETER APPROVAL gives the firm its first high pressure balloon catheter for percutaneous transluminal coronary angioplasty. Medtronic began sales of the Millenia catheter, which lists at $715, in early October following approval of a premarket application supplement Sept. 25. The PMA supplement to the firm's Omniflex PTCA catheter was filed with FDA in April. The device has been available in Australia, Canada and the European Union since August.
You may also be interested in...
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.